| Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates JK Nair, H Attarwala, A Sehgal, Q Wang, K Aluri, X Zhang, M Gao, J Liu, ... Nucleic acids research 45 (19), 10969-10977, 2017 | 215 | 2017 |
| Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates CR Brown, S Gupta, J Qin, T Racie, G He, S Lentini, R Malone, M Yu, ... Nucleic acids research 48 (21), 11827-11844, 2020 | 165 | 2020 |
| Reversal of siRNA-mediated gene silencing in vivo I Zlatev, A Castoreno, CR Brown, J Qin, S Waldron, MK Schlegel, ... Nature biotechnology 36 (6), 509-511, 2018 | 75 | 2018 |
| MICROBIAL PRODUCTION OF STEVIOL GLYCOSIDES R Philippe, AP Kumaran, J Donald, K Patel, S Gupta, R Lim, L LI US Patent App. 15/524,015, 2017 | 20 | 2017 |
| Reverse Transcription Quantitative Polymerase Chain Reaction Methods to Support Pharmacokinetics and Drug Mechanism of Action to Advance Development of RNA Interference … YX Elena Castellanos-Rizaldos,Christopher R. Brown, Sean Dennin, Joohwan Kim ... NUCLEIC ACID THERAPEUTICS, 2020 | 5 | 2020 |
| Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ... Molecules 27 (12), 3944, 2022 | 1 | 2022 |
| Correction: Clua et al. Properties of Parallel Tetramolecular G-Quadruplex Carrying N-Acetylgalactosamine as Potential Enhancer for Oligonucleotide Delivery to Hepatocytes … A Clua, S Grijalvo, N Erande, S Gupta, K Yucius, R Gargallo, S Mazzini, ... Molecules 28 (1), 98, 2022 | | 2022 |
Muthiah ManoharanAlnylam確認したメール アドレス: alnylam.com
